Pepdox
Studies
Peptides
Calculator
In brief: Higher-dose semaglutide (Ozempic) for type 2 diabetes. | Pepdox
Home
/
Search
/
PMID 35536124
In brief: Higher-dose semaglutide (Ozempic) for type 2 diabetes.
The Medical letter on drugs and therapeutics
2022
PMID: 35536124
View on PubMed
Semaglutide
Keywords
Ozempic
Rybelsus
Wegovy
adverse effects
dosage
efficacy
safety
semaglutide
type 2 diabetes